| IN LEARNING AND MEMORY PM Moran, PC Moser, LS Higgins, B Cordell ALZHEIMER DISEASE, 145, 1996 | 666 | 1996 |
| Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. PM Moran, LS Higgins, B Cordell, PC Moser Proceedings of the National Academy of Sciences 92 (12), 5341-5345, 1995 | 449 | 1995 |
| The pharmacology of latent inhibition as an animal model of schizophrenia PC Moser, JM Hitchcock, S Lister, PM Moran Brain Research Reviews 33 (2-3), 275-307, 2000 | 264 | 2000 |
| Latent inhibition: the nucleus accumbens connection revisited JA Gray, PM Moran, G Grigoryan, SL Peters, AMJ Young, MH Joseph Behavioural brain research 88 (1), 27-34, 1997 | 178 | 1997 |
| A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam AO Mechan, PM Moran, MJ Elliott, AM Young, MH Joseph, RA Green Psychopharmacology 159 (2), 188-195, 2002 | 138 | 2002 |
| Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist PC Moser, PM Moran, RA Frank, JH Kehne Behavioural brain research 73 (1-2), 163-167, 1995 | 123 | 1995 |
| Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning MH Joseph, SL Peters, PM Moran, GA Grigoryan, AMJ Young, JA Gray Neuroscience 101 (4), 921-930, 2000 | 114 | 2000 |
| Reduced Kamin blocking in non paranoid schizophrenia: associations with schizotypy PM Moran, MM Al-Uzri, J Watson, MA Reveley Journal of Psychiatric Research 37 (2), 155-163, 2003 | 97 | 2003 |
| The role of dopamine in conditioning and latent inhibition: what, when, where and how? AMJ Young, PM Moran, MH Joseph Neuroscience & Biobehavioral Reviews 29 (6), 963-976, 2005 | 92 | 2005 |
| Effects of clozapine on latent inhibition in the rat PM Moran, TR Fischer, JM Hitchcock, PC Moser Behavioural Pharmacology 7 (1), 42-48, 1996 | 91 | 1996 |
| A study of the effect of a single neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA;" ecstasy") on the subsequent long-term behaviour of rats in the plus maze and … AO Mechan, PM Moran, MJ Elliott, AM Young, MH Joseph, RA Green Psychopharmacology 159 (2), 167-175, 2002 | 89 | 2002 |
| Differential effects of scopolamine and mecamylamine on working and reference memory in the rat PM Moran Pharmacology Biochemistry and Behavior 45 (3), 533-538, 1993 | 81 | 1993 |
| Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia CMP O'Tuathaigh, BP Kirby, PM Moran, JL Waddington Schizophrenia Bulletin 36 (2), 271-288, 2010 | 79 | 2010 |
| Seasonal influences on admissions for affective disorder and schizophrenia in Ireland: a comparison of first and readmissions M Clarke, P Moran, F Keogh, M Morris, A Kinsella, C Larkin, D Walsh, ... European psychiatry 14 (5), 251-255, 1999 | 68 | 1999 |
| Gene× environment interactions in schizophrenia: evidence from genetic mouse models P Moran, J Stokes, J Marr, G Bock, L Desbonnet, J Waddington, ... Neural plasticity 2016, 2016 | 67 | 2016 |
| Schizotypy is increased in mixed-handers, especially right-handed writers who use the left hand for primary actions M Annett, P Moran Schizophrenia Research 81 (2-3), 239-246, 2006 | 63 | 2006 |
| The effect of amphetamine on Kamin blocking and overshadowing CMP O'Tuathaigh, C Salum, AMJ Young, AD Pickering, MH Joseph, ... Behavioural pharmacology 14 (4), 315-322, 2003 | 47 | 2003 |
| The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats AL McIntosh, TM Ballard, LJ Steward, PM Moran, KCF Fone Psychopharmacology 228, 31-42, 2013 | 44 | 2013 |
| Abnormal prediction error is associated with negative and depressive symptoms in schizophrenia PM Moran, L Owen, AE Crookes, MM Al-Uzri, MA Reveley Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (1), 116-123, 2008 | 44 | 2008 |
| Latent inhibition is attenuated by noise and partially restored by a 5-HT2A receptor antagonist LM McDonald, PM Moran, GN Vythelingum, MH Joseph, JD Stephenson, ... Behavioural Pharmacology 13 (8), 663-667, 2002 | 39 | 2002 |
Paul MoserCerbascience Pharma ConsultingVerified email at cerbascience.com
